Skip to content
OpenCapital
Get started

OneSpan OSPN Concentration Risk %

Concentration Risk % at other companies

Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Innoviva, Inc. logo
Innoviva, Inc.INVA
36%+7.0pp
Strattec Security logo
Strattec SecuritySTRT
0.5%0.0pp

Segments

By geography

See full
EMEA43%-12.2%
Americas38%+15.2%
APAC19%+5.6%

Other financials

Income statement

See full
Revenue$65.9M+4.1%
Gross profit$48.5M+3.0%
Operating income$14.8M-13.8%
Net income$11.6M-20.3%
EPS (diluted)$0.30-18.9%

Balance sheet

See full
Cash & equivalents$49.8M-52.8%
Total debt$8.0M-10.7%
Total equity$272.0M+17.7%
Total assets$383.1M+14.8%

Cash flow

See full
Operating cash flow$28.2M-4.1%
CapEx$3.1M+91.9%
Free cash flow$25.1M-9.7%

Valuation

See full
Market cap$501.6M-14.2%
Enterprise value$459.8M-5.9%
P/E7.2×-2.9×
P/S2×-0.4×

Profitability

See full
Gross margin73.6%+1.5pp
Operating margin18.8%-1.1pp
Net margin28.5%+4.4pp
FCF margin19.5%-1.3pp

Returns & leverage

See full
Return on equity27.8%-1.1pp
Debt / equity0×0.0×
Current ratio1.3×-0.7×